Biotech news for Wednesday, May 27, 2026, ranked by our 5-dimension investment framework — regulatory, technology, commercial, manufacturing, and narrative.
Annovis Bio ( ANVS ) said on Tuesday it restored compliance with NYSE listing standards. The company received an NYSE deficiency notice on March 26, 2025, after its average global market capitalization and equity fell below $50M. The NYSE approved the company'…
Editas Medicine ( EDIT ) shares fell nearly -12% premarket on Tuesday after the gene editing company launched an underwritten public offering of its common stock (or pre-funded warrants to purchase shares of common stock in lieu thereof) and accompanying warra…
Torsten Asmus The semi-annual rebalancing of U.S. equities is officially underway after FTSE Russell unveiled its preliminary list of shifts for the broad-market Russell 3000 Index on Monday . Highlighting a major sector realignment across the healthcare and b…
Torsten Asmus FTSE Russell kicked off its highly anticipated semi-annual index reconstitution by releasing a preliminary roster of projected additions and deletions for the Russell Microcap Index on Monday . The initial reshuffle features a significant rotatio…
Greenwich LifeSciences ( GLSI ) on Friday said it has received notification from Nasdaq, notifying the company that, because it has not yet filed its Quarterly Report on Form 10-Q for the three months ended March 31, 2026, it is not currently in compliance wit…
XTL Biopharmaceuticals ( XTLB ) has received a letter from Nasdaq notifying the company of its non-compliance with its listing rules due to its failure to file the annual report on Form 20-F for the year ended December 31, 2025, The company
The Nasdaq Composite Index ( COMP:IND ) ended flat but in the green on Friday, pushed up by tech stocks. It closed +0.19%. Chip and AI-related stocks were largely in the green over hopes of positive talks with Iran. Firms like Qualcomm (
Justin Sullivan/Getty Images News The US FDA has approved Gilead Sciences' Hepcludex (bulevirtide), the first-ever therapy for chronic hepatitis delta virus (" HDV" ) infection. Accelerated approval was based on results from a phase 3 trial that showed combine…
Shares of Inovio Pharmaceuticals ( INO ) traded higher on Friday after its partner in China, ApolloBio, succeeded in a Phase 3 pivotal trial for its therapeutic DNA vaccine, VGX-3100, against cervical dysplasia. Based on topline data, the Chinese biomedical co…
georgeclerk H.C. Wainwright downgraded Summit Therapeutics ( SMMT ) to Neutral from Buy, citing overhang from a new late-stage trial readout for sac-TMT, a lung cancer therapy developed by Merck ( MRK ) in partnership with Chinese company Kelun-Biotech. Accord…
Liminatus Pharma ( LIMN ) said on Friday that it has received a delisting notice from Nasdaq. On May 20, 2026, the company received a notice from Nasdaq stating that it had not regained compliance with Nasdaq's continued listing rules. Earlier, Luminatus was n…